Clever Leaves Reports Fourth Quarter and Full Year 2023 Results
- 2023 Revenue Increased 6% Year-Over-Year, with a 39% Increase in Full-Year Cannabinoid Revenue -- Drove Year-over-Year General and Administrative...
- 2023 Revenue Increased 6% Year-Over-Year, with a 39% Increase in Full-Year Cannabinoid Revenue -- Drove Year-over-Year General and Administrative...
Contacts INVESTOR RELATIONS Bonnie Bishop, Executive Director, Investor Relations Baldwin Risk Partners 813.259.8032 | IR@baldwinriskpartners.com PRESS Anna R. Rozenich, Senior...
REDWOOD CITY, Calif., April 01, 2024 (GLOBE NEWSWIRE) -- Biomea Fusion, Inc. (Nasdaq: BMEA) (“Biomea” or the “Company”), a clinical...
FORT LAUDERDALE, Fla., April 01, 2024 (GLOBE NEWSWIRE) -- BurgerFi International, Inc. (Nasdaq: BFI, BFIIW) (“BurgerFi” or the “Company”), owner BurgerFi, one...
FORT LAUDERDALE, Fla., April 01, 2024 (GLOBE NEWSWIRE) -- BurgerFi International, Inc. (Nasdaq: BFI, BFIIW) (“BurgerFi” or the “Company”), owner BurgerFi, one...
BURLINGTON, Mass., April 1, 2024 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced the publication of its annual Environmental, Social,...
SEATTLE, April 01, 2024 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) (“Atossa” or the “Company”), today announced financial results...
Contacts For iLearningEngines: Investor Contacts: iLearningEngines investors@ilearningengines.com Kevin Hunt iLearningEnginesIR@icrinc.com Media Contact: For Arrowroot Acquisition Corp.: Jessica Schmitt jschmitt@arrowrootcapital.com For...
PHOENIX, April 01, 2024 (GLOBE NEWSWIRE) -- Mobivity Holdings Corp. (the “Company”) (OTCQB: MFON), a provider of technology connecting mobile gaming...
CARLSBAD, Calif., April 01, 2024 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB) today reported results...
Contacts Tierney Saccavino tsaccavino@acorda.com Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced that it will no longer hold its fourth quarter...
Contacts Investor Contact: Acadia Pharmaceuticals Inc. Al Kildani (858) 261-2872 ir@acadia-pharm.com Acadia Pharmaceuticals Inc. Jessica Tieszen (858) 261-2950 ir@acadia-pharm.com Acadia...
ATLANTA, April 01, 2024 (GLOBE NEWSWIRE) -- Atlantic American Corporation (Nasdaq- AAME) today reported net loss for the three month...
Contacts Cynthia L. Volk Senior Vice President Chief Financial Officer 1-856-358-7000 ELMER BANCORP, INC. (“Elmer Bancorp” or the “Company”) (OTC...
-Granted global commercial license to Vision Bioenergy for Camelina addressing the biofuel market-Advanced regulatory and seed scale-up program for omega-3...
On track with plans to initiate Phase 2 trial for XTX101, a tumor-activated, Fc-enhanced anti-CTLA-4, in combination with atezolizumab in...
Annual Revenue Grows to a Record $38.0 Million, Marking a 34% IncreaseNet Income Increases to $8.4 Million in 2023CHANDLER, Ariz.,...
Contacts Investor Relations: David Atchley, datchley@verisign.com, 703-948-3447 Media Relations: David McGuire, davmcguire@verisign.com, 703-948-3800 VeriSign, Inc. (NASDAQ: VRSN), a global provider...
Leading ag tech deal creates an industry-leading, mixed-fleet precision ag platform serving farmers globally DULUTH, Ga. and WESTMINSTER, Colo., April 1,...
FREDERICK, Md., April 01, 2024 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc.® (“TOMI”) (NASDAQ: TOMZ), a global company specializing in...
Contacts Investor Relations Contact Martin Lam IR@atlassian.com Media Contact Marie-Claire Maple press@atlassian.com Atlassian Corporation (NASDAQ: TEAM), a leading provider of...
SANTA FE, N.M., April 1, 2024 /PRNewswire/ -- Thornburg Income Builder Opportunities Trust (the "Trust") (NASDAQ: TBLD) today announced a...
CULVER CITY, Calif., April 01, 2024 (GLOBE NEWSWIRE) -- Snail, Inc. (NASDAQ: SNAL) (“Snail” or “the Company”), a leading, global...
MIAMI, April 01, 2024 (GLOBE NEWSWIRE) -- SKYX Platforms Corp. (NASDAQ: SKYX) (d/b/a SKYX Technologies) (the “Company” or “SKYX”), a...
NEW YORK, April 01, 2024 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on health...
--Record annual revenue increased 85.3% year-over-year to $17.6 million in 2023--Loan Book Value increased 194.2% to $55.6 million in 2023,...
EDINBURG, Va., April 01, 2024 (GLOBE NEWSWIRE) -- Shenandoah Telecommunications Company (“Shentel” or the “Company”) (Nasdaq: SHEN) announced today the...
STUART, Fla., April 01, 2024 (GLOBE NEWSWIRE) -- Seacoast Banking Corporation of Florida (NASDAQ: SBCF), a bank holding company whose...
Completed First Surgeries With Next-Generation Lap-Band® 2.0 FLEX2024 Operating Expenses Expected to Decrease by more than 50% Compared to 2023;...
TARRYTOWN, N.Y., April 01, 2024 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that it will report its...
SAN JOSE, Calif., April 1, 2024 /PRNewswire/ -- QuickLogic Corporation (NASDAQ: QUIK), a developer of embedded FPGA (eFPGA) IP, ruggedized FPGAs...
SAN DIEGO, April 1, 2024 /PRNewswire/ -- Poseida Therapeutics, Inc. (Nasdaq: PSTX), a clinical-stage cell and gene therapy company advancing a...
Delivers Positive Full-Year Net Income vs. Net Loss in 2022; Backlog Surges to $46 Million; up 36% Sequentially; Expects Continued,...
– Conference Call Today at 4:30 p.m. ET Contacts Jennifer Cook Williams Cook Williams Communications, Inc. Investor and Media Relations...
CAMBRIDGE, Mass., April 01, 2024 (GLOBE NEWSWIRE) -- Korro Bio, Inc. (Korro) (Nasdaq: KRRO) today announced that Chief Executive Officer...
ORLANDO, Fla., April 01, 2024 (GLOBE NEWSWIRE) -- IZEA Worldwide, Inc. (NASDAQ: IZEA), a premier provider of influencer marketing technology,...
CARLSBAD, Calif., April 01, 2024 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB) today reported results...
-Project Continued Growth from Sales of AmnioWrap2®--Financial Results Conference Call and Webcast on Monday, April 1, 2024 at 4:30 pm EDT-Read...
– Company demonstrates improved performance with record revenue and operating income in fiscal year 2023 –– Q4 2023 revenue of...
-- Early progression-free survival (PFS) trends favor GRANITE recipients with hazard ratios of 0.82 in the overall population (; 62%...